AKT1 and ovarian carcinoma: Knocking down mTOR by shRNA decreased paclitaxel-induced Akt phosphorylation at Ser473 but not at Thr308 and it also caused CaOV3 ovarian cancer cells to become more sensitive to paclitaxel (30).